Newsroom press releases

29/12/20 - 18:22

DiaSorin has received BARDA Funding in support of submitting the SIMPLEXA COVID-19 Direct Kit for 510(k) clearance (400.67 KB)

Products Molecular

Download

01/12/20 - 6:33

DiaSorin received FDA approval for its LIAISON® XL MUREX HIV Ab/Ag assay, completing the Hepatitis and Retrovirus offer in the US market (566.6 KB)

Products Immunodiagnostic

Download

26/10/20 - 18:30

DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients (414.59 KB)

Products Immunodiagnostic

Download

01/10/20 - 7:45

DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market (395.31 KB)

Products Immunodiagnostic

Download

01/10/20 - 7:32

DiaSorin’s LIAISON SARS-CoV-2 IgM test receives FDA Emergency Use Authorization for the U.S. market (488.09 KB)

Products Immunodiagnostic

Download

16/09/20 - 7:25

DiaSorin Simplexa™ COVID-19 Direct molecular test CE marked for saliva specimens (477.67 KB)

Products Molecular

Download

07/09/20 - 18:22

FDA approval of Simplexa flu A_B & RSV Direct Gen II Assay (400.26 KB)

Products Molecular

Download

06/08/20 - 7:25

DiaSorin announces the launch of its new CE marked LIAISON Testosterone xt test for the dosage of testosterone (391.91 KB)

Products Immunodiagnostic

Download

09/07/20 - 7:27

DiaSorin will provide the UK Government with its LIAISON SARS-CoV-2 S1/S2 IgG serology kit for COVID-19 testing to run a national screening study (399.63 KB)

Products Immunodiagnostic

Download

07/07/20 - 7:22

DiaSorin CE marks their new Simplexa Flu A/B & RSV Direct Gen II Assay to run with the Simplexa COVID-19 Direct assay (490.1 KB)

Products Molecular

Download

30/06/20 - 7:25

DiaSorin announces the launch of its new LIAISON® SARS-COV-2 IgM test, a new fully automated serology kit available in Europe and in the U.S. to identify the immediate response to SARS-COV-2 in COVID-19 patients (397.37 KB)

Products Immunodiagnostic

Download

12/06/20 - 7:30

DiaSorin has CE marked its molecular's Simplexa™ Congenital CMV Direct Assay (478.6 KB)

Products Molecular

Download

03/06/20 - 14:16

The LIAISON® SARS-COV-2 S1/S2 IgG test received the approval for the commercialization in Brazil from ANVISA (397.21 KB)

Products Immunodiagnostic

Download

18/05/20 - 11:28

The LIAISON® SARS-COV-2 S1S2 IgG test is the first to receive the approval from Health Canada (308.26 KB)

Products Immunodiagnostic

Download

25/04/20 - 16:49

DiaSorin - FDA EUA and BARDA funding for SARS-CoV-2 IgG (403.66 KB)

Products Immunodiagnostic

Download

17/04/20 - 18:25

DiaSorin has CE marked its SARS-COV-2 IgG serology kit for COVID-19 (464.49 KB)

Products Immunodiagnostic

Download

07/04/20 - 7:14

IgG test to detect immune response to SARS-CoV-2 (394.92 KB)

Products Immunodiagnostic

Download

20/03/20 - 7:28

DiaSorin COVID-19 test has received FDA Emergency Use Authorization (397.04 KB)

Products Molecular

Download

13/03/20 - 17:16

DiaSorin received BARDA funding to develop a rapid COVID-19 test (403.34 KB)

Products Molecular

Download

10/03/20 - 8:20

DiaSorin - Development of Coronavirus test (404.03 KB)

Products Molecular

Download

21/12/18 - 11:30

DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)

Products Molecular

Download

19/11/18 - 15:00

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)

Products Molecular

Download

17/10/18 - 11:51

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)

Products Molecular

Download

12/10/18 - 11:47

DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)

Products Molecular

Download

17/09/18 - 11:28

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)

Products Immunodiagnostic

Download

27/07/18 - 12:00

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)

Products Immunodiagnostic

Download

12/06/18 - 14:15

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)

Products Molecular

Download

05/04/18 - 12:00

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)

Products Immunodiagnostic

Download

28/03/18 - 18:45

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)

Products Molecular

Download

Newsroom press releases

Select year

Newsroom press category

DiaSorin has received BARDA Funding in support of submitting the SIMPLEXA COVID-19 Direct Kit for 510(k) clearance (400.67 KB)

DiaSorin received FDA approval for its LIAISON® XL MUREX HIV Ab/Ag assay, completing the Hepatitis and Retrovirus offer in the US market (566.6 KB)

DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients (414.59 KB)

DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market (395.31 KB)

DiaSorin’s LIAISON SARS-CoV-2 IgM test receives FDA Emergency Use Authorization for the U.S. market (488.09 KB)

DiaSorin Simplexa™ COVID-19 Direct molecular test CE marked for saliva specimens (477.67 KB)

FDA approval of Simplexa flu A_B & RSV Direct Gen II Assay (400.26 KB)

DiaSorin announces the launch of its new CE marked LIAISON Testosterone xt test for the dosage of testosterone (391.91 KB)

DiaSorin will provide the UK Government with its LIAISON SARS-CoV-2 S1/S2 IgG serology kit for COVID-19 testing to run a national screening study (399.63 KB)

DiaSorin CE marks their new Simplexa Flu A/B & RSV Direct Gen II Assay to run with the Simplexa COVID-19 Direct assay (490.1 KB)

DiaSorin announces the launch of its new LIAISON® SARS-COV-2 IgM test, a new fully automated serology kit available in Europe and in the U.S. to identify the immediate response to SARS-COV-2 in COVID-19 patients (397.37 KB)

DiaSorin has CE marked its molecular's Simplexa™ Congenital CMV Direct Assay (478.6 KB)

The LIAISON® SARS-COV-2 S1/S2 IgG test received the approval for the commercialization in Brazil from ANVISA (397.21 KB)

The LIAISON® SARS-COV-2 S1S2 IgG test is the first to receive the approval from Health Canada (308.26 KB)

DiaSorin - FDA EUA and BARDA funding for SARS-CoV-2 IgG (403.66 KB)

DiaSorin has CE marked its SARS-COV-2 IgG serology kit for COVID-19 (464.49 KB)

IgG test to detect immune response to SARS-CoV-2 (394.92 KB)

DiaSorin COVID-19 test has received FDA Emergency Use Authorization (397.04 KB)

DiaSorin received BARDA funding to develop a rapid COVID-19 test (403.34 KB)

DiaSorin - Development of Coronavirus test (404.03 KB)

DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)

DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)

Price Sensitive